References
- Bingen E, Levy C, Varon E et al. Méningites à pneumocoque: impact du vaccin antipneumococcique heptavalent conjugué. Arch Pédiatrie. 2008; 15(5):543-4.
- Word Health Organization. Weekly Epidemiological Record, 1 December 2017, 92(48):729-748. October 2017. Accessed on 17 Jan 2019.
- Kayemba-Kay's S, Badran AM, Lagneaux C et al. Streptococcus pneumoniae serotype 19A meningitis in well-vaccinated immunocompetent 13-month-old child: a case of PCV13 failure. Clin Case Rep. 2016;4(11):1023-5. Google Scholar
- Diawara I, Zerouali K, Elmdaghri N et al. A case
report of parapneumonic pleural effusion caused by Streptococcus pneumoniae
serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
BMC Pediatr. 2017; 17(1):114. PubMed | Google
Scholar
- Elmdaghri N, Benbachir M, Belabbes H et al. Changing
epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine
introduction in Casablanca (Morocco). Vaccine. 2012; 30 (Suppl 6):G46-50. PubMed | Google
Scholar
- Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2010; 59(RR-11):1-18. PubMed | Google Scholar
- Moore CE, Paul J, Foster D et al. Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England. J Infect Dis. 2014; 210(7):1001-11. PubMed | Google Scholar
- Harboe ZB, Valentiner-Branth P, Ingels H et al. Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark. PLOS ONE. 2013; 8(1):e51460. PubMed | Google Scholar
- Godot C, Levy C, Varon E et al. Pneumococcal Meningitis
Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal
Conjugate Vaccination in Children in France. Pediatr Infect Dis J. 2015; 34(10):e260-263. PubMed | Google
Scholar
- Diawara I, Zerouali K, Katfy K et al. Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2015; 40:95-101. PubMed | Google Scholar
- Lepoutre A, Varon E, Georges S et al. Impact
of the pneumococcal conjugate vaccines on invasive pneumococcal disease in
France, 2001-2012. Vaccine. 2015; 33(2):359-66. PubMed | Google
Scholar
- Hon KL, Ip M, Lee K et al. Childhood pneumococcal
diseases and serotypes: can vaccines protect? Indian J Pediatr. 2010; 77(12):1387-91. PubMed | Google
Scholar
- Joye S, Gao A, Kayemba-Kay's S et al. Invasive
pneumococcal infection despite 7-valent conjugated vaccine. Clin Pract. 2013;
3(1):e11. PubMed | Google
Scholar
- Grant LR, O'Brien SE, Burbidge P et al. Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes. PloS One. 2013; 8(9):e74906. PubMed | Google Scholar
- Bouskraoui M, Soraa N, Zahlane K et al. Étude
du portage rhinopharyngé de Streptococcus pneumoniae et de sa sensibilité aux
antibiotiques chez les enfants en bonne santé âgés de moins de 2 ans dans la
région de Marrakech (Maroc). Arch Pédiatrie. 2011; 18(12):1265-70. Google
Scholar
- Revilla F, OPAS/OMS. Reports
of the Technical Advisory Group (TAG) on Vaccine-preventable Diseases. Pan
Am Health Organization.
10 July 2018. Accessed on 16 Jan 2019
- Oliveira LH de, Camacho LAB, Coutinho ESF et al.
Impact and Effectiveness of 10 and 13-Valent Pneumococcal conjugate vaccines
on hospitalization and mortality in children aged less than 5 Years in Latin
American Countries: a Systematic Review. PLOS ONE. 2016; 11(12):e0166736. Google
Scholar
- Word Health Organization. SAGE meeting of October 2017. 17-19 October 2017. Accessed on 17 Jan 2019.
- Organisation Mondiale de la Santé. Relevé épidémiologique
hebdomadaire (REH). 6 avril 2012; 87(14):129-144. Accessed on 16
Jan 2019.
- Palmu AA, Jokinen J, Borys D et al. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial. Lancet Lond Engl. 2013; 381(9862):214-22. PubMed | Google Scholar